Other Solid Tumors Recruiting Phase 1 / 2 Trials for Irinotecan (DB00762)
Also known as: Other Solid Tumor
Indication | Status | Phase |
---|---|---|
DBCOND0030393 (Other Solid Tumors) | Recruiting | 1 / 2 |
clinicaltrials.gov Identifier | Title | Purpose | Drugs |
---|---|---|---|
NCT04256707 | Relative Bioavailability/Bioequivalence of Different Formulations of Selinexor, the Impact of Hepatic Impairment on Selinexor Pharmacokinetics, Tolerability and Antitumor Activity of Selinexor Combination Treatment | Treatment |